Anti-Inflammatory Effects of HDL in Mice With Rheumatoid Arthritis Induced by Collagen

Front Immunol. 2018 May 11:9:1013. doi: 10.3389/fimmu.2018.01013. eCollection 2018.

Abstract

Objective: To investigate the anti-inflammatory effects of high-density lipoprotein (HDL) in mice with rheumatoid arthritis (RA) induced by collagen.

Methods: Male DBA/1 mice (8-week-old) were divided into three groups: control (treated with saline), collagen-induced arthritis (CIA), and CIA + HDL. CIA was induced with bovine type II collagen, and after the injection of bovine type II collagen, the CIA + HDL group received an injection of HDL on day 28 followed by HDL injections four times every 3 days. Mice were weighed, the paws were scored, and paw thickness was measured beginning on day 21. Additionally, the levels of tumor necrosis factor-alpha (TNF-α) and IL-6 were measured by ELISA kits, tissue sections of paws were stained with hematoxylin and eosin, and the inflammatory signaling pathway was analyzed by western blotting.

Results: We found that the production of pro-inflammatory cytokines TNF-α and IL-6 in mice which received HDL decreased 45.14 and 35.02%, respectively. And we also found that HDL could significantly decrease the level of anti-type-II-collagen IgG2a and inhibit the neutrophil infiltration and cell proliferation and protect the ankle joint from type II collage-induced injury. Western blot analysis indicated that HDL could also inhibit the activation of the NF-κB, MAPK, and ERK signaling pathways in RA mice.

Conclusion: HDL can inhibit the inflammation induced by bovine type II collagen and the development of RA.

Keywords: collagen; high-density lipoprotein; inflammation; inflammatory cytokines; rheumatoid arthritis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Arthritis, Rheumatoid / chemically induced
  • Arthritis, Rheumatoid / drug therapy*
  • Cattle
  • Cell Proliferation
  • Collagen Type II
  • Inflammation / drug therapy*
  • Interleukin-6 / immunology
  • Lipoproteins, HDL / pharmacology*
  • Male
  • Mice
  • Mice, Inbred DBA
  • Neutrophil Infiltration
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Anti-Inflammatory Agents
  • Collagen Type II
  • Interleukin-6
  • Lipoproteins, HDL
  • Tumor Necrosis Factor-alpha